Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Telomerase RNA component (TERC/TER/TR) is a long non-coding RNA essential for telomerase enzymatic activity in eukaryotes. It serves as an internal template for reverse transcription, guiding the addition of telomeric DNA repeats by the telomerase reverse transcriptase (TERT) subunit[4][2][1][5][9]. The template region within TERC is highly conserved in structure but variable in sequence across organisms, and includes boundary elements that ensure precise telomere repeat synthesis. TERC is a core element of the telomerase ribonucleoprotein, binding both TERT and multiple telomerase accessory factors, and is critical for cellular longevity, stem cell maintenance, and cancer cell immortality[4][2][1][5][9]. Dysfunction or deficiency of the TERC RNA can result in telomere syndromes or age-associated diseases, and telomerase inhibition strategies (interfering with TERC or TERT) are under active clinical investigation for cancer treatment[4][9].
Competitive inhibition of telomerase template usage; Disruption of telomerase RNP assembly; RNP complex destabilization
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Telomerase RNA component (template subunit) (TERC, TR, TER).